Clinical trial
Phase I Serum-Free Cultured Thymus Transplantation in DiGeorge Anomaly, IND9836
NCT00849888 is registered in ClinicalTrials.gov with Sumitomo Pharma Switzerland GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Serum-Free Cultured Thymus Transplantation in DiGeorge Anomaly, IND9836
- Lead sponsor
- Sumitomo Pharma Switzerland GmbH
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- April 30, 2008
- Completion date
- February 28, 2011
- Enrollment
- 2 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
digeorge anomaly